Words of Wisdom
2012
Volume 61 - January
Re: The Single IncisionMini-sling Versus a Transobutaror Sling: A Comparative Study on MiniArc andMonarc Slings
De Ridder D, Berkers J, Deprest J, et al
Re: Ten-Year Survival Analysis for Renal Carcinoma Patients Treated With an Autologous Tumour Lysate Vaccine in an Adjuvant Setting
May M, Brookman-May S, Hoschke B, et al
Re: Should Intervening Benign Tissue Be Included in the Measurement of Discontinuous Foci of Cancer of Prostate Needle Biopsy? Correlation With Radical Prostatectomy Findings
Karram S, Trock BJ, Netto GJ, Epstein JI
Re: Factors Determining Functional Outcomes After Radical Prostatectomy: Robot-Assisted Versus Retropubic
Kim SC, Song C, Kim W, et al
Re: Comparative Effectiveness of Perineal Versus Retropubic and Minimally Invasive Radical Prostatectomy
Prasad SM, Gu X, Lavelle R, Lipsitz SR, Hu JC
Re: Office Based Transrectal Saturation Biopsy Improves Prostate Cancer Detection Compared to Extended Biopsy in the Repeat Biopsy Population
Zaytoun OM, Moussa AS, Gao T, Fareed K, Jones JS
2011
Volume 60 – December
Re: Tissue-Engineered Autologous Urethras for Patients Who Need Reconstruction: An Observational Study
Raya-Rivera A, Esquiliano DR, Yoo JJ, Lopez-Bayghen E,Soker S, Atala A
Re: A Common Mutation in the Defensin DEFB126 Causes Impaired Sperm Function and Subfertility
Tollner TL, Venners SA, Hollox EJ, et al
Re: A Common Mutation in the Defensin DEFB126 Causes Impaired Sperm Function and Subfertility
Tollner TL, Venners SA, Hollox EJ, et al
Re: Radical Nephrectomy and Inferior Vena Cava Thrombectomy: Outcomes in a Lower Volume PracticeCalhoun JB, Merchen TD, Brown JA
Re: Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer Jones CU, Hunt D, McGowan DG, et al
Re: Randomised Prostate Cancer Screening Trial: 20 Year Follow-up
Sandblom G, Varenhorst E, Rosell J, Lo¨fman O, Carlsson P
Re: Safety and Feasibility of the Prostatic Urethral Lift: A Novel, Minimally Invasive Treatment for Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Woo HH, Chin PT, McNicholas TA, et al.
Re: Adjuvant Androgen Deprivation for High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921 Study
Dorff TB, Flaig TW, Tangen CM, et al.
Re: The Risks and Benefits of 5a-Reductase Inhibitors for Prostate-Cancer Prevention
Theoret MR, Ning YM, Zhang JJ, Justice R, Keegan P, Pazdur R
Re: Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer
Park K, Tomlins SA, Mudaliar KM, et al
Re: Human-Specific Loss of Regulatory DNA and the Evolution of Human-Specific Traits
McLean CY, Reno PL, Pollen AA, et al
Re: Conventional-Dose Versus High-Dose Chemotherapy as First Salvage Treatment in Male Patients With Metastatic Germ Cell Tumors: Evidence From a Large International Database
Lorch A, Bascoul-Mollevi C, Kramar A, et al
Re: Prognostic Factors in Patients With Metastatic Germ Cell Tumors who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy
Lorch A, Beyer J, Bascoul-Mollevi C, et al
Re: Comorbidity and Mortality Results from a Randomised
Prostate Cancer Screening Trial Crawford ED, Grubb R III, Black A, et al
Re: Association of Statin Use with Pathological Tumor
Characteristics and Prostate Cancer Recurrence After Surgery
Mondul AM, Han M, Humphreys EB, et al
Re: Radical Prostatectomy Versus Watchful Waiting in Early Prostate Cancer Bill-Axelson A, Holmberg L, Ruutu M, et al
Re: Impact of Posterior Musculofascial Reconstruction on Early Continence After Robot-Assisted Radical Prostatectomy:Results of a Prospective Parallel Group Trial
Joshi N, de Blok W, von Muilekom E, van der Poel H
Re: International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial
Re: Abiraterone and Increased Survival in Metastatic Prostate Cancer
deBono JS, Logothetis CJ, Molina A, et al
Volume 60 – September
Re: Can Partial Nephrectomy Preserve Renal Function and Modify Survival in Comparison with Radical Nephrectomy?Medina-Polo J, Romero-Otero J, Rodrı´guez-Antolı´n A, et al
Re: Chronic Pudendal Neuromodulation: Expanding Available Treatment Options for Refractory Urologic Symptoms
Peters K, Killinger KA, Boguslawski BM, Boura JA
Re: Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience
Tosoian JJ, Trock BJ, Landis P, et al
Re: Delay of Surgery in Men with Low-Risk Prostate Cancer
O’Brien D, Loeb S, Carvalhal GF, et al
Re: Adjuvant Androgen Deprivation for High-Risk Prostate Cancer After Radical Prostatectomy:
SWOG S9921 Study
Dorff TB, Flaig TW, Tangen CM, et al
Re: A Prospective, Non-Randomized Trial Comparing Robot-Assisted Laparoscopic and Retropubic Radical Prostatectomy in One European Institution
Ficarra V, Novara G, Fracalanza S, et
Volume 60 – August
Re: Population-Based Patterns and Predictors of Prostate-Specific Antigen Screening Among Older Men in the United States
Vickers, A.
Re: Active Surveillance Compared With Initial Treatment for Men With Low-Risk Prostate Cancer: A Decision Analysis
Lu-Yao, G.
Re: Comparative Risk-Adjusted Mortality Outcomes After Primary Surgery, Radiotherapy, or Androgen-Deprivation Therapy for Localized Prostate Cancer
Cathcart,P, Costello, A.
Re: In Vitro Production of Functional Sperm in Cultured Neonatal Mouse Testes
Maya, W.
Re: Does Varicocele Repair Improve Male Infertility? An Evidence-Based Perspective From a Randomized, Controlled Trial
Eisenberg, M, Lipshultz, L.
Re: Biopsy Misidentification Identified by DNA Profiling in a Large Multicenter Trial
Bostwick, D.
Volume 60 - July
Re: Prospective Evaluation of Operating Characteristics of Prostate Cancer Detection Biomarkers
Roobol, MJ.
Re: Magnetic Resonance Imaging Guided Prostate Biopsy in Men With Repeat Negative Biopsies and Increased Prostate Specific AntigenPonholzer, A, Madersbacher, S.
Re: Prostate Cancer Antigen 3 Score Accurately Predicts Tumour Volume and Might Help in Selecting Prostate Cancer Patients for Active Surveillance
Kakehi, Y.
Re: Predictors of Androgen Deprivation Therapy Efficacy Combined with Prostatic Irradiation: The Central Role of Tumor Stage and Radiation Dose Mason, M.
Re: Posterior Rhabdosphincter Reconstruction During Robotic Assisted Radical Prostatectomy: Results from a Phase II Randomized Clinical Trial
Coelho, RF, Chauhan, S, Patel, V.
Re: Comparison of Cold and Warm Ischemia During Partial Nephrectomy in 660 Solitary Kidneys Reveals Predominant Role of Nonmodifiable Factors in Determining Ultimate Renal Function
Navarrete, RV.
Volume 59 - June
Re: Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder Lamm, D, L.
Re: Acceptance and Durability of Surveillance as a Management Choice in Men with Screen-Detected, Low-Risk Prostate Cancer: Improved Outcomes with Stringent Enrollment Criteria
Katz, A, E, Capodice, J, L.
Re: Salvage Therapy With Bicalutamide 150 mg in Nonmetastatic Castration-resistant Prostate Cancer Kliment, J.Re: Revision of Current American Association for the Surgery of Trauma Renal Injury Grading System
Erickson, B, A.
Re: An International Urogynecological Association (IUGA)/International Continence Society (ICS) Joint Terminology and Classification of the Complications Related Directly to the Insertion of Prostheses (Meshes, Implants, Tapes) and Grafts in Female Pelvic Floor Surgery Heesakkers, J.
Re: A Randomized Comparison of Totally Tubeless and Standard Percutaneous Nephrolithotomy in Elderly Patients
Nadler, B, N.
Volume 59 - May
Re: Efficacy and Safety of an Orodispersible Vardenafil Formulation for the Treatment of Erectile Dysfunction in Elderly Men and Those With Underlying Conditions: An Integrated Analysis of Two Pivotal Trials
Hatzimouratidis, K.
Re: Management of Disseminated Nonseminomatous Germ Cell Tumors with Risk-Based Chemotherapy Followed by Response-Guided Postchemotherapy Surgery
Jewett, M.
Re: The Influence of Family History on Prostate Cancer Risk: Implications for Clinical Management
Klingler, C.
Re: Active Surveillance Compared with Initial Treatment in Men with Low-Risk Prostate Cancer: A Decision Analysis
Albertsen, M.
Re: Active Surveillance Compared with Initial Treatment for Men with Low-Risk Prostate Cancer: A Decision Analysis
Nepple, K, Kibel, A.
Volume 59 - April
Re: Testicular Spermatozoa Have Statistically Significantly Lower DNA Damage Compared With Ejaculated Spermatozoa in Patients With Unsuccessful Oral Antioxidant Treatment
Hwang, K, Lamb, D,J.
Re: Prednisone Plus Cabazitaxel or Mitoxantrone for Metastatic Castration-Resistant Prostate Cancer Progressing After Docetaxel Treatment: A Randomised Open-Label Trial
Beuzeboc, P.
Re: Prednisone Plus Cabazitaxel or Mitoxantrone for Metastatic Castration-Resistant Prostate Cancer Progressing After Docetaxel Treatment: A Randomized Open-Label Trial
Jocham, D, Sommerauer, M.
RE: Mortality Results From the Göteborg Randomised Population-Based Prostate-Cancer Screening Trial
Ito, K.
Volume 59 - March
Re: Adverse Events Associated With Testosterone AdministrationMorgentaler, A.
Re: Ketoconazole and Prednisone to Prevent Recurrent Ischemic Priapism Kadioglu, A, Küçükdurmaz, F.
Re: Five Year Biochemical Recurrence Free Survival for Intermediate Risk Prostate Cancer After Radical Prostatectomy, External Beam Radiation Therapy or Permanent Seed Implantation
Janetschek, G.
Re: Active Surveillance for Larger (cT1bN0M0 and cT2N0M0) Renal Cortical Neoplasms
Cutress, ML, Tolley, DA.
Volume 59 - February
Re: Variations in Treatment Policies and Outcome for Bladder Cancer in the Netherlands
Simon Horenblas
Re: Use of Radical Cystectomy for Patients with Invasive Bladder Cancer
Harry W. Herr
Re: Randomized Phase III Trial on Gemcitabine Versus Mytomicin in Recurrent Superficial Bladder Cancer: Evaluation of Efficacy and Tolerance
Edward N. Rampersaud Jr., Arie S. Belldegrun
Re: Potential Impact of Postoperative Early Complications on the Timing of Adjuvant Chemotherapy in Patients Undergoing Radical Cystectomy: A High-Volume Tertiary Cancer Center Experience
Ed Messing
Re: How Close Are We to Knowing Whether Orthotopic Bladder Replacement Surgery Is the New Gold Standard? Evidence From a Systematic Review Update
Richard E. Hautmann
Re: Prostate Specific Antigen Concentration at Age 60 and Death or Metastasis From Prostate Cancer: Case-Control Study
Carlo Terrone
Volume 59 - January
Re: Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly Men Wu FC, Tajar A, Beynon JM, et al., EMAS Study Group.
Re: Treatment of Erectile Dysfunction in the Obese Type 2 Diabetic ZDF Rat With Adipose Tissue-Derived Stem Cells Garcia MM, Fandel TM, Lin G, et al.
Re: Combination Therapy for Premature Ejaculation: Results of a Small-Scale Study Steggall MJ, Fowler CG, Pryce A.
Re: The Learning Curve for Surgical Margins After Open Radical Prostatectomy: Implications for the Use of Margin Status as an Oncologic Endpoint Vickers A, Bianco F, Cronin A, et al.
Re: Pharmacological Prevention of Side Effects of Androgen Deprivation Therapy, A New Challenge? Smith MR, Morton RA, Barnette KG, et al.
Re: Outcomes of Lumbar to Sacral Nerve Rerouting for Spina Bifida Peters KM, Girdler B, Turzewski C, et al.
2010
Volume 58 - December
Re: Mortality Results from the Go¨teborg Randomised Population-Based Prostate-Cancer Screening Trial Hugosson J, Carlsson S, Aus G, et al
Re: Three-Dimensional Prostate Mapping Biopsy Has a Potentially Significant Impact on Prostate Cancer Management Onik G, Miessau M, Bostwick DG
Re: Effects of Tadalafil on Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia in Men With or Without Erectile Dysfunction Broderick GA, Brock GB, Roehrborn CG, Watts SD, Elion-Mboussa A, Viktrup L
Re: A Sequence Variant at 4p16.3 Confers Susceptibility to Urinary Bladder Cancer Kiemeney LA, Sulem P, Besenbacher S, et al
Volume 58 - November
Re: Biological, Clinical, and Ethical Advances of Placebo Effects Finniss DG, Kaptchuck TJ, Miller F, Benedetti F
Re: Comparison of Warm Ischemia Versus No Ischemia During Partial Nephrectomy on a Solitary Kidney Thompson RH, Lane BR, Lohse CM, et al
Re: Impact of Previous Radiotherapy for Prostate Cancer on Clinical Outcomes of Patients with Bladder Cancer Yee DS, Shariat SF, Lowrance WT, et al
Re: Does Computed Tomography or Positron Emission Tomography/Computed Tomography Contribute to Detection of Small Focal Cancers in the Prostate?
Li MM, Rybalov M, Haider MA, de Jong IJ
Re: The Index Lesion and Focal Therapy: An Analysis of the Pathological Characteristics of Prostate Cancer Bott SRJ, Ahmed HU, Hindley RG, Abdul-Rahman A, Freeman A, Emberton M
Volume 58 - October
Re: Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk: A Science Advisory From the American Heart Association, American Cancer Society,
and American Urological Association: Endorsed by the American Society for Radiation Oncology Levine GN, D’Amico AV, Berger P, et al
Re: Effect of Dutasteride on the Risk of Prostate Cancer Andriole GL, Bostwick DG, Brawley OW, et al; REDUCE Study Group
Re: Overall Survival Analysis of a Phase II Randomized
Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer Kantoff PW, Schuetz TJ, Blumenstein BA, et al
Re: Penile Reconstruction: Is the Radial Forearm Flap Really the Standard Technique? Monstrey S, Hoebeke P, Selvaggi G, et al
Volume 58 - September
Re: Preoperative Aspects and Dimensions Used for an Anatomical (PADUA) Classification of Renal Tumours in Patients Who Are Candidates for Nephron-Sparing Surgery
Remzi, M. Klatte, T. Waldert, M
Re: Increased Risk of High-Grade Prostate Cancer Among Infertile Men
Oosterlinck, W.
Re: Post-Prostatectomy Urinary Incontinence: A Confluence of 3 Factors
Romics, I. Majoros, A.
Re: Antitumour Activity of MDV3100 in Castration-Resistant Prostate Cancer: A Phase 1–2 Study
Miller, K.
Re: Effect of Dutasteride on the Risk of Prostate Cancer
Sooriakumaran, P. Tewari, A.
Re: Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
Finley, D.S. Pouliot, F
Volume 58 - 2 August 2010
Re: Phase 1 Trial of High-Dose Exogenous Testosterone in Patients with Castration-Resistant Metastatic Prostate Cancer
Lange PH
Re: Effect of Dutasteride on the Risk of Prostate Cancer
Madersbacher S
Re: Effect of Dutasteride on the Risk of Prostate Cancer
Klotz L
Re: Does Oral Antiandrogen Use Before Leuteinizing Hormone-Releasing Therapy in Patients with Metastatic Prostate Cancer Prevent Clinical Consequences of a Testosterone Flare?
Pavone-Macaluso M
Re: Retrospective Analysis of Prostate Cancer Recurrence Potential with Tissue Metabolomic Profiles
Sciarra A
Re: Carbonic Anhydrase IX in Renal Cell Carcinoma: Implications for Prognosis, Diagnosis, and Therapy
Sciarra A
Volume 58 - 1 July 2010
Re: Randomized Phase III Trial on Gemcitabine Versus Mytomicin in Recurrent Superficial Bladder Cancer: Evaluation of Efficacy and Tolerance
Malmström P-U
Re: The perils of commercially driven surgical innovation
Galloway NTM
Re: Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort with Localized Prostate Cancer
Ploussard G, Mongiat-Artus P
Re: Peripheral Zone Prostate Cancers: Location and Intraprostatic Patterns of Spread at Histopathology
Montironi R, Mazzucchelli R, Lopez-Beltran A et al
Re: Lower Testosterone Levels Predict Incident Stroke and Transient Ischemic Attack in Older Men
Morales A
Re: The Role of Pathology Review of Transurethral Bladder Tumor Resection Specimens in the Modern Era
Newling DWW
Volume 57 - 6 June 2010
Re: Reduced Bladder Cancer Recurrence Rate with Cardioprotective Aspirin After Intravesical Bacille Calmette-Guérin
Grossman HB
Re: Urinary Diversion and Morbidity After Radical Cystectomy for Bladder Cancer
Maffezzini M
Re: Randomized Phase III Trial on Gemcitabine Versus Mytomicin in Recurrent Superficial Bladder Cancer: Evaluation of Efficacy And Tolerance
Lotan Y
Re: Laparoscopic Versus Open Nephroureterectomy: Perioperative and Oncologic Outcomes From a Randomised Prospective Study
Greco F, Fornara P
Re: Comparative Effectiveness of Minimally Invasive Versus Open Radical Prostatectomy
Koupparis AJ, Gleave ME
Re: The Role of Short Frenulum and the Effects of Frenulectomy on Premature Ejaculation
Jannini EA
Volume 57 - 5 May 2010
Re: Survival Benefit of Radical Prostatectomy in Lymph Node–Positive Patients with Prostate Cancer
Gomella LG
Re: Time of Decline in Sexual Function After External Beam Radiotherapy for Prostate Cancer
Incrocci L
Re: Testicular Microlithiasis and Carcinoma In Situ Overview and Proposed Clinical Guideline
Meuleman E
Re: Penile Sonographic and Clinical Characteristics in Men with Peyronie's Disease
Hatzimouratidis K
Re: Early Sacral Neuromodulation Prevents Urinary Incontinence After Complete Spinal Cord Injury
Kessler TM
Re: MicroRNA Regulation of Oncolytic Herpes Simplex Virus-1 for Selective Killing of Prostate Cancer Cells
Schaefer A, Jung K
Volume 57- 4 April 2010
Re: Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
Marks LS, Huang J
Re: Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium
Logothetis CJ, Siefker-Radtke A
Re: Sex and racial differences in bladder cancer presentation and mortality in the US
Stenzl A
Re: Treatment of non-muscle invading bladder cancer: do physicians in the United States practice evidence based medicine?
Colombo R
Re: Prostate-sparing cystectomy: long-term oncological results
Horenblas S
Re: Corporal “snake” maneuver: corporaglanular shunt surgical modification for ischemic priapism
Kadioglu A, Sanli O, Simsek A
March
Volume 57- 3 March 2010
Re: Comparative Effectiveness of Minimally Invasive vs Open Radical Prostatectomy
Lowrance WT, Elkin EB, Scardino PT et al
Re: Comparative Effectiveness of Minimally Invasive vs Open Radical Prostatectomy
van Leeuwen PJ
Re: Rethinking Screening for Breast Cancer and Prostate Cancer
Herr HW
Re: Radical Prostatectomy Findings in Patients in Whom Active Surveillance of Prostate Cancer Fails
van den Bergh RCN
Re: Periprostatic Adipose Tissue as a Modulator of Prostate Cancer Aggressiveness
Stenman U-H
Re: Effects of Simvastatin, Acetylsalicylic Acid, and Rosiglitazone on Proliferation of Normal and Cancerous Prostate Epithelial Cells at Therapeutic Concentrations
Masko EM, Bañez LL, Freedland SJ
February
Volume 57- 2 February 2010
Re: Open to Debate. The Motion: Perioperative Chemotherapy in Muscle Invasive Bladder Cancer Improves Survival
Brausi MA
Re: Comparative Effectiveness of Minimally Invasive vs Open Radical Prostatectomy
de Vere White R
Re: Reducing Laparoscopic Radical Prostatectomy False-positive Margin Rates Using Cyanoacrylate Tissue Glue
Peyromaure M
Re: Anti-androgens and Androgen-depleting Therapies in Prostate Cancer: New Agents for an Established Target
Beuzeboc P
Re: Maternal Smoking, Alcohol, and Coffee Use During Pregnancy and Son's Risk of Testicular Cancer
Albrecht W
Re: XMRV Is Present in Malignant Prostate Epithelium and Is Associated With Prostate Cancer, Especially High-grade Tumors
Trottier G, Fleshner NE
January
Volume 57-1 January 2010
Re: Spontaneous Release of Acetylcholine from Autonomic Nerves in the Bladder
Andersson K-A
Re: Erectile Dysfunction in Type 2 Diabetic Men: Relationship to Exercise Fitness and Cardiovascular Risk Factors in the Look AHEAD Trial
Raynor MC, Hellstrom WJG
Re: Fertility Preservation in Adolescent Males: Experience Over 22 Years at Rouen University Hospital
Hwang K, Lamb DJ
Re: Does Reflux in Orthotopic Diversion Matter? A Randomized Prospective Comparison of the Studer and T-Pouch Ileal Neobladders
Fontana D, Destefanis P
Re: Outcome After Radical Cystectomy with Limited or Extended Pelvic Lymph Node Dissection
Bochner BH, Tarin T
Re: Estimating the Benefits of PSA Screening
Roobol MJ, Schröder FH
